Radiomics-guided prediction of overall survival (OS) in brain gliomas is seen as a significant problem in Neuro-oncology. The ultimate goal is to develop a robust MRI-based approach (i.e., a radiomics model) that can accurately classify a novel subject as a short-term survivor, a medium-term survivor, or a long-term survivor. The BraTS 2020 challenge provides radiological imaging and clinical data (178 subjects) to develop and validate radiomics-based methods for OS classification in brain gliomas. In this study, we empirically evaluated the efficacy of four multiregional radiomic models, for OS classification, and quantified the robustness of predictions to variations in automatic segmentation of brain tumor volume. More specifically, we e...
Funder: National Institute for Health Research; doi: http://dx.doi.org/10.13039/501100000272Abstract...
Objectives The aim of this study was to investigate whether radiomic analysis with random survival f...
Background and Purpose: Biopsy is the main determinants of glioma clinical management, but require i...
Glioblastoma is recognized as World Health Organization (WHO) grade IV glioma with an aggressive gro...
ObjectiveTo compare the performance of radiomics-based machine learning survival models in predictin...
Background: This study aims to identify robust radiomic features for Magnetic Resonance Imaging (MR...
Glioblastoma is an aggressive brain tumor with a low survival rate. Understanding tumor behavior by ...
Radiomics analysis has had remarkable progress along with advances in medical imaging, most notabili...
Glioblastoma multiforme is the most frequent and aggressive primary brain tumor in humans. Due to it...
Glioblastoma (known as glioblastoma multiforme) is one of the most aggressive brain malignancies, ac...
International audienceGlioblastoma (GBM) is the most common and aggressive primary brain tumor in ad...
Introduction:Being the most common primary brain tumor, glioblastoma presents as an extremely challe...
Radiomics, in combination with artificial intelligence, has emerged as a powerful tool for the devel...
Funder: National Institute for Health Research; doi: http://dx.doi.org/10.13039/501100000272Abstract...
Objectives The aim of this study was to investigate whether radiomic analysis with random survival f...
Background and Purpose: Biopsy is the main determinants of glioma clinical management, but require i...
Glioblastoma is recognized as World Health Organization (WHO) grade IV glioma with an aggressive gro...
ObjectiveTo compare the performance of radiomics-based machine learning survival models in predictin...
Background: This study aims to identify robust radiomic features for Magnetic Resonance Imaging (MR...
Glioblastoma is an aggressive brain tumor with a low survival rate. Understanding tumor behavior by ...
Radiomics analysis has had remarkable progress along with advances in medical imaging, most notabili...
Glioblastoma multiforme is the most frequent and aggressive primary brain tumor in humans. Due to it...
Glioblastoma (known as glioblastoma multiforme) is one of the most aggressive brain malignancies, ac...
International audienceGlioblastoma (GBM) is the most common and aggressive primary brain tumor in ad...
Introduction:Being the most common primary brain tumor, glioblastoma presents as an extremely challe...
Radiomics, in combination with artificial intelligence, has emerged as a powerful tool for the devel...
Funder: National Institute for Health Research; doi: http://dx.doi.org/10.13039/501100000272Abstract...
Objectives The aim of this study was to investigate whether radiomic analysis with random survival f...
Background and Purpose: Biopsy is the main determinants of glioma clinical management, but require i...